182 related articles for article (PubMed ID: 8622906)
1. Facilitating oligonucleotide delivery: helping antisense deliver on its promise.
Gewirtz AM; Stein CA; Glazer PM
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3161-3. PubMed ID: 8622906
[No Abstract] [Full Text] [Related]
2. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
3. PEG-appended beta-(1-->3)-D-glucan schizophyllan to deliver antisense-oligonucleotides with avoiding lysosomal degradation.
Karinaga R; Koumoto K; Mizu M; Anada T; Shinkai S; Sakurai K
Biomaterials; 2005 Aug; 26(23):4866-73. PubMed ID: 15763266
[TBL] [Abstract][Full Text] [Related]
4. Thermodynamic criteria for high hit rate antisense oligonucleotide design.
Matveeva OV; Mathews DH; Tsodikov AD; Shabalina SA; Gesteland RF; Atkins JF; Freier SM
Nucleic Acids Res; 2003 Sep; 31(17):4989-94. PubMed ID: 12930948
[TBL] [Abstract][Full Text] [Related]
5. TargetFinder: a software for antisense oligonucleotide target site selection based on MAST and secondary structures of target mRNA.
Bo X; Wang S
Bioinformatics; 2005 Apr; 21(8):1401-2. PubMed ID: 15598838
[TBL] [Abstract][Full Text] [Related]
6. How to design an antisense oligodeoxynucleotide experiment: a consensus approach.
Stein CA
Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):129-32. PubMed ID: 9593051
[No Abstract] [Full Text] [Related]
7. Antisense oligonucleotide-mediated inhibition of mutant p53 expression.
Ruddell CJ; Green JA; Tidd DM
Biochem Soc Trans; 1996 Aug; 24(3):410S. PubMed ID: 8878954
[No Abstract] [Full Text] [Related]
8. Therapeutic applications of antisense oligonucleotides in asthma and allergy.
Isidoro-García M; Dávila I
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):171-5. PubMed ID: 19075979
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory properties of double-helix-forming circular oligonucleotides.
Azhayeva E; Azhayev A; Auriola S; Tengvall U; Urtti A; Lönnberg
Nucleic Acids Res; 1997 Dec; 25(24):4954-61. PubMed ID: 9396802
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotides in the treatment of bladder cancer.
Glackin AJ; Gray SB; Johnston SR; Duggan BJ; Williamson KE
Expert Opin Biol Ther; 2005 Jan; 5(1):67-77. PubMed ID: 15709910
[TBL] [Abstract][Full Text] [Related]
11. Disruption of gene function using antisense morpholinos.
Angerer LM; Angerer RC
Methods Cell Biol; 2004; 74():699-711. PubMed ID: 15575627
[No Abstract] [Full Text] [Related]
12. Conformationally restricted carbohydrate-modified nucleic acids and antisense technology.
Herdewijn P
Biochim Biophys Acta; 1999 Dec; 1489(1):167-79. PubMed ID: 10807006
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotide technology in the development of cancer therapeutics.
Tseng BY; Brown KD
Cancer Gene Ther; 1994 Mar; 1(1):65-71. PubMed ID: 7621240
[No Abstract] [Full Text] [Related]
14. Variations in mRNA content have no effect on the potency of antisense oligonucleotides.
Miraglia L; Watt AT; Graham MJ; Crooke ST
Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):453-61. PubMed ID: 11198929
[TBL] [Abstract][Full Text] [Related]
15. Approaches for the sequence-specific knockdown of mRNA.
Scherer LJ; Rossi JJ
Nat Biotechnol; 2003 Dec; 21(12):1457-65. PubMed ID: 14647331
[TBL] [Abstract][Full Text] [Related]
16. [Suppression of gene function].
Bian XC; Liu YQ
Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):298-301. PubMed ID: 16777004
[No Abstract] [Full Text] [Related]
17. Making sense of antisense.
Murakami A
Trends Mol Med; 2001 Oct; 7(10):430-1. PubMed ID: 11597507
[No Abstract] [Full Text] [Related]
18. Identifying Suitable Target Regions and Analyzing Off-Target Effects of Therapeutic Oligonucleotides.
Pedersen L; Hagedorn PH; Koch T
Methods Mol Biol; 2019; 2036():261-282. PubMed ID: 31410803
[TBL] [Abstract][Full Text] [Related]
19. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo.
Griesenbach U; Kitson C; Escudero Garcia S; Farley R; Singh C; Somerton L; Painter H; Smith RL; Gill DR; Hyde SC; Chow YH; Hu J; Gray M; Edbrooke M; Ogilvie V; MacGregor G; Scheule RK; Cheng SH; Caplen NJ; Alton EW
Respir Res; 2006 Feb; 7(1):26. PubMed ID: 16480492
[TBL] [Abstract][Full Text] [Related]
20. RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus.
Liang XH; Sun H; Nichols JG; Crooke ST
Mol Ther; 2017 Sep; 25(9):2075-2092. PubMed ID: 28663102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
